Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
| Website | https://allarity.com/ |
| Employees | 11 (9 on RocketReach) |
| Founded | 2012 |
| Address | 123 E Tarpon Ave, Tarpon Springs, Florida 34689, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+25 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
Looking for a particular Allarity Therapeutics employee's phone or email?
Allarity Therapeutics Questions
Thomas Jensen is the CEO of Allarity Therapeutics.
9 people are employed at Allarity Therapeutics.
Allarity Therapeutics is based in Tarpon Springs, Florida.
Top Allarity Therapeutics Employees
-
15
-
Jeff Ervin
Chief Financial Officer at Allarity Therapeutics
Brentwood, TN, US25+ -
24
-
Joan Brown
Chief Financial Officer at Allarity Therapeutics
West Vancouver, BC, CA1 -
Nina Nordström
Executive assistant at Allarity Therapeutics
Hässleholm, SE1
